Edgewise Therapeutics's total assets for Q4 2024 were $486.82M, a decrease of -4.79% from the previous quarter. EWTX total liabilities were $27.60M for the fiscal quarter, a 23.19% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.